טוען...
An anti-TNF-α antibody mimetic to treat ocular inflammation
Infliximab is an antibody that neutralizes TNF-α and is used principally by systemic administration to treat many inflammatory disorders. We prepared the antibody mimetic Fab-PEG-Fab (FpF(infliximab)) for direct intravitreal injection to assess whether such formulations have biological activity and...
שמור ב:
| הוצא לאור ב: | Sci Rep |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Nature Publishing Group
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5118814/ https://ncbi.nlm.nih.gov/pubmed/27874029 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep36905 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|